Stock BIOL BIOLASE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. BIOLASE, Inc.

Equities

BIOL

US0909117022

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.148 USD 0.00% Intraday chart for BIOLASE, Inc. +6.47% -86.81%
Apr. 01 Ascendiant Capital Adjusts Biolase's Price Target to $4 From $15, Reiterates Buy Rating MT
Mar. 22 Wall Street Set to Open Marginally Lower Friday Following Powell Speech, After Hitting Record Highs Thursday MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ascendiant Capital Adjusts Biolase's Price Target to $4 From $15, Reiterates Buy Rating
MT
Wall Street Set to Open Marginally Lower Friday Following Powell Speech, After Hitting Record Highs Thursday
MT
Biolase Files Registration Statement for Unit Offering at Target Price of $60 a Unit
MT
Lake Street Adjusts Price Target on Biolase to $0.40 From $1.50, Maintains Buy Rating
MT
Lake Street Assumes Biolase at Buy With $1.50 Price Target
MT
Lake Street Initiates Biolase at Buy, Sets Price Target at $12
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIOL Stock
  4. News BIOLASE, Inc.
  5. Analyst Reco.